ERBB3 and pancreatic neoplasm: We demonstrated that VPA inhibits proliferation/survival of pancreatic cancer cells as well as induces caspase-dependent apoptosis selectively in EGFR/ErbB2/ErbB3-coexpressing pancreatic cancer within its clinically achievable range.